BioAdvance News

GenPro Selected to Lead Epigenetic Profiling on Multi-Company Multi-Institution Team Formed to Discover New Precision Medicine Hypotheses for Undiagnosed Diseases

By WebmasterAugust 15, 2016November 1st, 2024No Comments

GenPro Selected to Lead Epigenetic Profiling on Multi-Company Multi-Institution Team Formed to Discover New Precision Medicine Hypotheses for Undiagnosed Diseases

See more here

Previous PostNew Data on Posiphen in Traumatic Brain Injury
Next PostBioAdvance Commits $2.9M to 15 Life Sciences Companies

GenPro Selected to Lead Epigenetic Profiling on Multi-Company Multi-Institution Team Formed to Discover New Precision Medicine Hypotheses for Undiagnosed Diseases

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostNew Data on Posiphen in Traumatic Brain Injury

Next PostBioAdvance Commits $2.9M to 15 Life Sciences Companies